Antisense Therapeutics Limited (AU:PER) has released an update.
Percheron Therapeutics Limited has disclosed full compliance with the ASX Corporate Governance Council’s recommendations for the financial year ended 30 June 2024, as detailed on their website. The company’s corporate governance statement is current as of 29 August 2024 and is approved by the board, ensuring transparency and adherence to high standards of management and oversight.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
